Related Experiment Video
Updated: Feb 1, 2026

Author Spotlight: Simulating Pediatric Cardiac Surgery Using a Neonatal Piglet Model
Published on: May 26, 2023
Indications and Outcomes for Temporary Mechanical Circulatory Support in Pediatric Patients with Cardiac Failure
David W Bearl1, Robert D B Jaquiss2, Travis P Vesel3
1From the Monroe Carell Jr. Children's Hospital at Vanderbilt, Nashville, Tennessee.
Insights
Temporary continuous-flow ventricular assist devices (cfVAD) offer longer support for pediatric patients than extracorporeal membrane oxygenation (ECMO), facilitating recovery, durable VAD transition, or transplant.
Area of Science:
- Pediatric Cardiology
- Mechanical Circulatory Support
- Cardiovascular Surgery
Background:
- Temporary mechanical circulatory support is crucial for pediatric patients with severe heart failure.
- Continuous-flow ventricular assist devices (cfVAD) and extracorporeal membrane oxygenation (ECMO) are primary options.
- Limited pediatric literature exists for temporary cfVAD use.
Purpose of the Study:
- To compare the outcomes of temporary cfVAD and ECMO in pediatric patients.
- To evaluate the duration of support and patient disposition for each device.
- To assess the role of temporary cfVAD as a bridge to durable VAD or transplant.
Main Methods:
- Single-center retrospective review of pediatric patients (<19 years) from January 2011 to June 2016.
- Comparison of 13 patients receiving temporary cfVAD with 11 patients receiving ECMO for similar indications.
- Analysis of precannulation data, duration of support, and patient outcomes (recovery, transplant, death).
Main Results:
- Median cfVAD support duration was 20 days (range 6-227) vs. 9 days (range 1-15) for ECMO.
- cfVAD patients: 1 recovered, 6 transplanted, 6 died.
- ECMO patients: 5 recovered, 3 transplanted after durable VAD conversion, 3 died. No direct ECMO-to-transplant.
- No significant difference in precannulation data, except higher lactate and lower pH in ECMO cohort.
Conclusions:
- Temporary cfVAD can provide longer mechanical circulatory support in pediatric patients compared to ECMO.
- cfVAD facilitates transition to durable VAD and subsequent heart transplantation.
- cfVAD represents a viable option for pediatric mechanical circulatory support, improving outcomes and bridging to definitive therapy.
Abstract:
Temporary continuous-flow ventricular assist devices (cfVAD) and extracorporeal membrane oxygenation (ECMO) are options for temporary mechanical circulatory support in pediatric patients. Despite the increase in temporary cfVAD use, the literature describing its use in pediatrics is limited. This was a single-center retrospective review of temporary cfVAD and a cohort of similar ECMO patients between January 1, 2011, and June 30, 2016, in patients <19 years of age. Thirteen patients underwent temporary cfVAD placement and 11 patients underwent ECMO cannulation for similar indications during the study period. Precannulation data were not statistically different, except for higher lactate and lower pH in the ECMO cohort. Median length of cfVAD support was 20 days (range 6-227), compared with 9 days (range 1-15) on ECMO. Primary outcome for cfVAD patients was one decannulated with recovery, six transplanted, and six died, compared with ECMO patients with five decannulated with recovery, three transplanted after conversion to durable VAD, and three died. No patients were transplanted directly from ECMO. This review provides new evidence that temporary cfVAD use can be used to support pediatric patients more than longer periods of time compared with ECMO, with transition to durable VAD and transplant.
Related Concept Videos
Mechanical Ventilation I: Indication and Settings
Pharmacokinetics in Pediatric Patients: Drug Excretion
Pharmacokinetics in Pediatric Patients: Drug Distribution
Pharmacokinetics in Pediatric Patients: Drug Metabolism
Indicators
Anatomy of the Circulatory System

